Your browser doesn't support javascript.
loading
Effect of vaccination on the prevention of influenza-related severe illness in adults attended in a third level hospital during the 2017-2018 epidemic season. / Efecto de la vacunación en la prevención de gripe grave en adultos atendidos en un hospital de tercer nivel durante la temporada 2017-2018.
Mena, Guillermo; Casas, Irma; Prat, Cristina; Casañ, Cristina; Esteve, María; Urrutia, Agustín; Mòdol, Josep-Maria.
Afiliação
  • Mena G; Servicio de Medicina Preventiva, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
  • Casas I; Servicio de Medicina Preventiva, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain. Electronic address: icasas.germanstrias@gencat.cat.
  • Prat C; Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain; Servicio de Microbiologia, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; CIBER Enfermedades respiratorias.
  • Casañ C; Servicio de Microbiologia, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Esteve M; Servicio de Medicina Preventiva, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
  • Urrutia A; Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain; Servicio de Medicina Interna, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Mòdol JM; Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain; CIBER Enfermedades respiratorias; Dirección Médica, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Med Clin (Barc) ; 155(3): 112-118, 2020 08 14.
Article em En, Es | MEDLINE | ID: mdl-32423688
ABSTRACT

OBJECTIVES:

The objective of this research was to evaluate the effect of influenza vaccination on the prevention of influenza-related severe cases in adults treated in a third-level hospital during the 2017-2018 epidemic season.

METHODOLOGY:

A descriptive analysis was performed on the entire population of subjects with a laboratory-confirmed influenza test during the 2017-2018 season. A severe case was defined as a patient treated in one of the Intensive Care Units (ICUs) and/or death. The effect of the vaccine on the adult population was determined by multivariate logistic regression analysis.

RESULTS:

Between epidemiological weeks 44/2017 and 19/2018, the hospital's laboratory detected 706 positive samples for influenza virus. Of the 551 confirmed patients aged 18 years or older, forty-three were admitted to one of the ICUs, and 26 died during admission. The explanatory multivariate model has shown that flu vaccination prior to or during the epidemic season was a protective factor for the development of severity [OR0.27 (0.11-0.65, p=0.004)], adjusted by age [OR 1.03 (1.01-1.06), p=.04], sex, type of virus (H1N1-pdm09, H3N2 or B virus), Chronic Complex Patient index or Advanced Chronic Disease index. CONCLUSSIONS Influenza vaccination is a protective factor against the development of severity associated with influenza infection in a season when vaccination did not contain the virus with higher epidemic circulation among the population. Flu vaccination should be recommended annually following the guidelines established by the health authorities.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Epidemias Idioma: En / Es Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Epidemias Idioma: En / Es Ano de publicação: 2020 Tipo de documento: Article